William Desmarais is Chief Business Officer at TScan Therapeutics, Inc. (TCRX). They have made 1 open-market trade across 1 company since 2021, most recently 2021-08-27.
CIK 0001860207
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $23K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TCRX | 2,500 | $522 |
Shares reported on the most recent Form 4, priced at the 2021-08-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TCRX | BUY | 2021-08-27 | 2021-08-31 | $9.08 | $23K | -16.2% | -8.6% | -13.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.